Literature DB >> 9685432

Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children.

D Wilson-Costello1, E Borawski, H Friedman, R Redline, A A Fanaroff, M Hack.   

Abstract

BACKGROUND AND
OBJECTIVE: The etiology of neurologic impairments among very low birth weight (VLBW, <1.5 kg) children is poorly understood. We sought to investigate the perinatal predictors of major neurologic impairment, including cerebral palsy, among VLBW children.
METHODS: Antenatal, intrapartum, and neonatal events and therapies were compared between 72 singleton inborn VLBW children born between 1983 to 1991 who had neurologic impairment at 20 months corrected age (including 50 with cerebral palsy and 22 with other neurologic impairments) and 72 neurologically normal VLBW children matched by birth weight, gestational age, race, and sex via a retrospective case-control method. Multiple logistic regression was conducted, entering only those variables found to be significant at the bivariate level.
RESULTS: There were no significant differences in the rates of pregnancy-induced hypertension, maternal tocolytic use including magnesium, or antenatal steroid therapy. Higher rates of clinical chorioamnionitis were found among the mothers of the neurologically impaired children as compared with controls (31% vs 11%), but not among the subgroup of mothers of children with cerebral palsy (22% vs 12%). Significant differences in neonatal factors among the total neurologically-impaired group (n = 72) versus controls included oxygen dependence at 36 weeks (31% vs 15%), septicemia (53% vs 31%), severe cranial ultrasound abnormality (50% vs 17%), and hypothyroxinemia (43% vs 25%). In the subgroup with cerebral palsy (n = 50), significant differences included days on the ventilator (23 vs 14 days), septicemia (54% vs 33%), and severe cranial ultrasound abnormality (52% vs 12%). Multivariate analysis controlling for birth weight, gestational age, race, sex, and the birth period (before 1990 versus 1990 and after) revealed direct and independent effects of clinical chorioamnionitis [odds ratio (OR), 3. 79; confidence interval (CI), 1.34-10.78], severe cranial ultrasound abnormality (OR, 9.97; CI, 3.84-25.87), and septicemia (OR, 2.46; CI, 1.10-5.52) on total neurologic impairment. Consideration of the 50 cases with cerebral palsy revealed direct and independent effects of severe cranial ultrasound abnormality only (OR, 15.01; CI, 4.34-51. 93).
CONCLUSIONS: Both antenatal and neonatal risk factors contribute to the development of severe neurologic impairment, including cerebral palsy among VLBW children. Because prevention of chorioamnionitis may not be feasible in the near future, attempts to decrease neonatal risk factors such as severe cranial ultrasound abnormalities and sepsis may be most feasible at this time.

Entities:  

Mesh:

Year:  1998        PMID: 9685432     DOI: 10.1542/peds.102.2.315

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Neonatal cranial ultrasound interpretation: a clinical audit.

Authors:  P R Reynolds; R C Dale; F M Cowan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  Colonization pattern of coagulase-negative staphylococci in preterm neonates and the relation to bacteremia.

Authors:  M Björkqvist; M Liljedahl; J Zimmermann; J Schollin; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-02       Impact factor: 3.267

3.  Frontal horn thin walled cysts in preterm neonates are benign.

Authors:  B R Pal; P R Preston; M E Morgan; D I Rushton; G M Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 4.  Chorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review.

Authors:  Zhongjie Shi; Lin Ma; Kehuan Luo; Monika Bajaj; Sanjay Chawla; Girija Natarajan; Henrik Hagberg; Sidhartha Tan
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

5.  Diffusion tensor imaging-demonstrated differences between hemiplegic and diplegic cerebral palsy with symmetric periventricular leukomalacia.

Authors:  H K Cho; S H Jang; E Lee; S Y Kim; S Kim; Y H Kwon; S M Son
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

6.  Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.

Authors:  Sabine Zoghbi Bousleiman; Madeline Murguia Rice; Joan Moss; Allison Todd; Monica Rincon; Gail Mallett; Cynthia Milluzzi; Donna Allard; Karen Dorman; Felecia Ortiz; Francee Johnson; Peggy Reed; Susan Tolivaisa
Journal:  Am J Obstet Gynecol       Date:  2015-05-06       Impact factor: 8.661

7.  Maternal antenatal complications and the risk of neonatal cerebral white matter damage and later cerebral palsy in children born at an extremely low gestational age.

Authors:  Thomas F McElrath; Elizabeth N Allred; Kim A Boggess; Karl Kuban; T Michael O'Shea; Nigel Paneth; Alan Leviton
Journal:  Am J Epidemiol       Date:  2009-08-27       Impact factor: 4.897

Review 8.  Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.

Authors:  Agustín Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2009-06       Impact factor: 8.661

9.  Cerebral palsy in triplet pregnancies with and without iatrogenic reduction.

Authors:  Gabriel Dimitriou; Peter O D Pharoah; Kypros H Nicolaides; Anne Greenough
Journal:  Eur J Pediatr       Date:  2004-06-08       Impact factor: 3.183

10.  Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2 years in children born at extremely low gestational age.

Authors:  Karl C K Kuban; Elizabeth N Allred; T Michael O'Shea; Nigel Paneth; Marcello Pagano; Olaf Dammann; Alan Leviton; Adré Du Plessis; Sjirk J Westra; Cindy R Miller; Haim Bassan; Kalpathy Krishnamoorthy; Joseph Junewick; Nicholas Olomu; Elaine Romano; Joanna Seibert; Steve Engelke; Padmani Karna; Daniel Batton; Sunila E O'Connor; Cecelia E Keller
Journal:  J Child Neurol       Date:  2009-01       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.